Literature DB >> 875735

Amino acid modulation of glucose-induced insulin and glucagon release in diabetic patients.

Y Seino, M Ikeda, K Nakane, H Nakahara, S Seino.   

Abstract

In order to determine whether amino acids have a beneficial effect on glucose tolerance in diabetes, the effect of intravenous infusion of mixed amino acids on plasma insulin, glucagon, and blood glucose responses to oral glucose loading was studied in patients with mild to moderate diabetes. Intravenous infusion of mixed amino acids over a period of 30 min which was started 30 min or immediately before oral glucose loading significantly augmented the insulin response but did not improve the blood glucose curve, probably due to excessive glucagon response. However, amino acid infusion over a period of 60 min started immediately before oral glucose loading evoked a sustained rise of plasma insulin associated with a lesser degree of glucagon secretion, thus causing significant improvement of the blood glucose curve.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875735     DOI: 10.1016/0026-0495(77)90010-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Insulinopenia in impaired glucose tolerance preservation of insulin response to I.V. arginine and tolbutamide.

Authors:  J P Monson; L J Borthwick; G S Spathis; S R Bloom
Journal:  Acta Diabetol Lat       Date:  1980 Jan-Mar

2.  High-Protein Diets for Treatment of Type 2 Diabetes Mellitus: A Systematic Review.

Authors:  Samar Malaeb; Caitlin Bakker; Lisa S Chow; Anne E Bantle
Journal:  Adv Nutr       Date:  2019-07-01       Impact factor: 8.701

3.  Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ.

Authors:  Qian Zhou; Wan-Wan Sun; Jia-Cong Chen; Hui-Lu Zhang; Jie Liu; Yan Lin; Peng-Cheng Lin; Bai-Xing Wu; Yan-Peng An; Lin Huang; Wen-Xing Sun; Xin-Wen Zhou; Yi-Ming Li; Yi-Yuan Yuan; Jian-Yuan Zhao; Wei Xu; Shi-Min Zhao
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.